ArticleJournal of robotic surgery2025
Gastric bypass performed with different surgical platforms during different periods.
Article in Journal of robotic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Transitioning From Laparoscopic to Robotic Bariatric Surgery: A Surgeon-Centered Analytic Approach.Obesity surgery · 2026Article
- Initial Single-Center Experience with Robotic Roux-en-Y Gastric Bypass: A Retrospective Case Series.Journal of clinical medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Robotic gastric bypass (RGB) continues to increase. However, conflicting data remain on its impact on patient-reported outcomes. We utilized the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Project (MBSAQIP) databases. Gastric bypass cases performed with laparoscopy (LGB) or robotic assistance (RGB) between 2015 and 2021 were analyzed. A 1:1 matched analysis compared outcomes between LGB and RGB performed at different time intervals (2015-2018 vs. 2091-2021). 286,531 RYGB cases (87% LGB, 13% RGB) were analyzed, yielding 25,594 matched LGB and RGB cases. Mortality was low (0.1%) and comparable between cohorts. Surgical site infection (SSI) (0.9% vs. 1.3%, p < 0.001) and bleeding (0.3% vs. 0.4%, p = 0.04) were lower with RGB; however, readmission (5.8% vs. 4.9%, p < 0.001), reoperation (2.2% vs. 1.85%, p = 0.005), and morbidity (7.6% vs. 6.8%, p < 0.001) were higher. Operative length (OL) was longer for RGB (p < 0.001). In the early cohort, SSI and bleeding (p = 0.002 and p = 0.039) were lower for RGB; however, operative duration and LOS (p < 0.001) were more extended. In the later cohort, SSI (p = 0.006) and bleeding (p = 0.046) remained lower with RGB, while morbidity was higher (p = 0.005). Mean OL narrowed but remained longer for RGB (p < 0.001), while LOS was comparable. Both RGB and LGB demonstrate safety profiles with low mortality and morbidity. With increased robotic utilization, RGB was associated with a persistently reduced incidence of SSI and bleeding but longer OL.
Indexed as
Identifiers
39976871What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.